SyntheticMR receives FDA 510(k) clearance for SyMRI 15 PR Newswire LINKÖPING, Sweden, Dec. 6, 2024 LINKÖPING, Sweden, Dec. 6, 2024 /PRNewswire/...
SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland PR Newswire LINKÖPING, Sweden, Oct. 2, 2024 LINKÖPING, Sweden, Oct. 2, 2024...
SyntheticMR Announces the Appointment of Francois Hebert as New President, North America PR Newswire LINKÖPING, Sweden, Sept. 4, 2024 LINKÖPING...
SyMRI 15 by SyntheticMR obtains CE-Marking PR Newswire LINKÖPING, Sweden, June 26, 2024 SyntheticMR announced today that version 15 of their...
SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's...
SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D PR Newswire LINKÖPING, Sweden, March 27, 2024 LINKÖPING...
Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients PR...
SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking PR Newswire LINKÖPING, Sweden, Dec. 18, 2023 LINKÖPING...
SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D PR Newswire LINKÖPING, Sweden, Nov. 30, 2023 LINKÖPING, Sweden, Nov...
SyntheticMR Partners with Hyland to Utilize PACSgear Modlink Software SyntheticMR US Inc finalized a new partnership with Hyland Healthcare...
SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) study PR Newswire STOCKHOLM, Jan. 27, 2022 STOCKHOLM, Jan. 27, 2022...
SyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens Healthineers PR...
SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems PR Newswire STOCKHOLM, June 9, 2021...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads